Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
IEEE Trans Pattern Anal Mach Intell ; 37(9): 1890-903, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26353134

ABSTRACT

Multiple view segmentation consists in segmenting objects simultaneously in several views. A key issue in that respect and compared to monocular settings is to ensure propagation of segmentation information between views while minimizing complexity and computational cost. In this work, we first investigate the idea that examining measurements at the projections of a sparse set of 3D points is sufficient to achieve this goal. The proposed algorithm softly assigns each of these 3D samples to the scene background if it projects on the background region in at least one view, or to the foreground if it projects on foreground region in all views. Second, we show how other modalities such as depth may be seamlessly integrated in the model and benefit the segmentation. The paper exposes a detailed set of experiments used to validate the algorithm, showing results comparable with the state of art, with reduced computational complexity. We also discuss the use of different modalities for specific situations, such as dealing with a low number of viewpoints or a scene with color ambiguities between foreground and background.

2.
J Med Chem ; 58(1): 362-75, 2015 Jan 08.
Article in English | MEDLINE | ID: mdl-25369539

ABSTRACT

The Aurora family of serine/threonine kinases is essential for mitosis. Their crucial role in cell cycle regulation and aberrant expression in a broad range of malignancies have been demonstrated and have prompted intensive search for small molecule Aurora inhibitors. Indeed, over 10 of them have reached the clinic as potential anticancer therapies. We report herein the discovery and optimization of a novel series of tricyclic molecules that has led to SAR156497, an exquisitely selective Aurora A, B, and C inhibitor with in vitro and in vivo efficacy. We also provide insights into its mode of binding to its target proteins, which could explain its selectivity.


Subject(s)
Antineoplastic Agents/pharmacology , Aurora Kinases/antagonists & inhibitors , Benzimidazoles/pharmacology , Protein Kinase Inhibitors/pharmacology , Quinolones/pharmacology , Small Molecule Libraries/pharmacology , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/metabolism , Aurora Kinase A/antagonists & inhibitors , Aurora Kinase A/chemistry , Aurora Kinase A/metabolism , Aurora Kinase B/antagonists & inhibitors , Aurora Kinase B/chemistry , Aurora Kinase B/metabolism , Aurora Kinase C/antagonists & inhibitors , Aurora Kinase C/chemistry , Aurora Kinase C/metabolism , Aurora Kinases/chemistry , Aurora Kinases/metabolism , Benzimidazoles/chemistry , Benzimidazoles/metabolism , Female , HCT116 Cells , Humans , Mice, SCID , Models, Chemical , Models, Molecular , Molecular Structure , Neoplasms/drug therapy , Neoplasms/pathology , Protein Binding , Protein Kinase Inhibitors/chemistry , Protein Kinase Inhibitors/metabolism , Protein Structure, Tertiary , Quinolones/chemistry , Quinolones/metabolism , Sf9 Cells , Small Molecule Libraries/chemistry , Small Molecule Libraries/metabolism , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...